Integrated transcriptomic analysis of human induced pluripotent stem cell-derived osteogenic differentiation reveals a regulatory role of KLF16
View abstract on PubMed
Summary
This summary is machine-generated.The study identified KLF16 as a key regulator of bone formation. Overexpressing KLF16 inhibited osteogenic differentiation, while KLF16 deficiency increased bone density in mice, revealing its inhibitory role in bone development.
Area Of Science
- Molecular Biology
- Stem Cell Biology
- Bone Biology
Background
- Osteogenic differentiation is crucial for bone health, but its genetic regulation is not fully understood.
- Identifying novel genes controlling this process is essential for understanding bone development, metabolism, and repair.
Purpose Of The Study
- To explore transcriptomic changes during osteogenic differentiation of human induced pluripotent stem cell (iPSC)-derived mesenchymal stem cells (MSCs).
- To identify novel regulatory genes, particularly transcription factors (TFs), involved in osteogenic differentiation.
- To investigate the specific role of KLF16 in osteogenic differentiation and bone homeostasis.
Main Methods
- Differentiated iPSC-derived MSCs into preosteoblasts (preOBs) and osteoblasts (OBs).
- Performed transcriptome profiling (RNA sequencing) at different differentiation stages.
- Utilized differential gene expression analysis, TF regulatory network analysis, and Multiscale Embedded Gene Co-expression Network Analysis (MEGENA).
- Validated KLF16 function through in vitro overexpression studies and in vivo experiments using KLF16 heterozygous (KLF16+/-) mice.
Main Results
- Transcriptome profiling revealed significant gene expression changes during osteogenic differentiation, including 840 differentially expressed TFs.
- TF network analysis identified a complex regulatory network, with KLF16 emerging as a key regulator.
- In vitro, KLF16 overexpression inhibited osteogenic differentiation and mineralization.
- In vivo, KLF16+/- mice showed increased bone mineral density, trabecular bone, and cortical bone area, confirming KLF16's inhibitory role.
Conclusions
- Osteogenic differentiation involves complex transcriptomic regulatory networks.
- KLF16 is a novel inhibitory regulator of osteogenic differentiation and bone formation.
- This study provides new insights into the genetic control of bone development and repair, highlighting KLF16 as a potential therapeutic target.
Related Concept Videos
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...

